Our allogeneic platform offers broader and faster treatment with cell therapies where speed and cost are paramount for patient access and where our proprietary potent cell format offers sufficient persistence.

Treatment Speed

Faster from diagnosis to treatment

Starting material from healthy donors

Cost

Simpler manufacturing process

1 batch ~ 1000 patients

Access

Off-the-shelf

Large treatment stock